Banced Corp’s Novartis NVS Stock Holding History

Banced Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,483	Closed	-$422K	–	62
2018 Q4	$422K	Sell	5,483 -141	-3%	-$11K	0.92%	44
2018 Q3	$434K	Sell	5,624 -250	-4%	-$18.5K	0.74%	55
2018 Q2	$398K	Buy	5,874 +633	+12%	+$43.7K	0.68%	65
2018 Q1	$380K	Sell	5,241 -115	-2%	-$8.75K	0.67%	64
2017 Q4	$403K	Buy	5,356 +101	+2%	+$7.62K	0.67%	69
2017 Q3	$404K	Sell	5,255 -636	-11%	-$48K	0.7%	67
2017 Q2	$441K	Sell	5,891 -214	-4%	-$15.2K	0.82%	60
2017 Q1	$406K	Sell	6,105 -245	-4%	-$16.3K	0.74%	62
2016 Q4	$414K	Buy	6,350 +828	+15%	+$53.7K	0.78%	58
2016 Q3	$391K	Sell	5,522 -77	-1%	-$5.61K	0.77%	66
2016 Q2	$461K	Buy	5,599 +450	+9%	+$31.1K	0.86%	46
2016 Q1	$334K	Buy	5,149 +82	+2%	+$5.58K	0.58%	72
2015 Q4	$391K	Sell	5,067 -532	-10%	-$42.3K	0.7%	57
2015 Q3	$461K	Sell	5,599 -1,096	-16%	-$97.5K	0.85%	47
2015 Q2	$590K	Buy	6,695 +221	+3%	+$20.3K	0.8%	38
2015 Q1	$572K	Sell	6,474 -1,014	-14%	-$89.9K	0.81%	39
2014 Q4	$622K	Buy	7,488 +169	+2%	+$14K	0.68%	44
2014 Q3	$617K	Buy	7,319 +690	+10%	+$55.8K	0.71%	41
2014 Q2	$538K	Buy	6,629 +3,386	+104%	+$266K	0.65%	51
2014 Q1	$247K	Sell	3,243 -1,485	-31%	-$108K	0.26%	164
2013 Q4	$341K	Sell	4,728 -248	-5%	-$17.2K	0.34%	121
2013 Q3	$342K	Sell	4,976 -1,235	-20%	-$81.7K	0.34%	116
2013 Q2	$394K	Buy	+6,211	New	+$404K	0.41%	104

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Banced Corp's NVS Position: Q1 2019 in Review

Banced Corp sold out of Novartis (NVS) in Q1 2019, closing a stake of 5,483 shares — an estimated $422K sold.

Banced Corp first reported a position in NVS in Q2 2013 and held it in 23 quarters. The position peaked at $622K in Q4 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Banced Corp reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Banced Corp sold 5,483 Novartis shares in Q1 2019, an estimated $422K.
Banced Corp first reported a position in Novartis in Q2 2013 and held it in 23 quarters.
Banced Corp's Novartis position peaked at $622K in Q4 2014.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.